Skip to main content
. Author manuscript; available in PMC: 2015 Feb 19.
Published in final edited form as: Adv Genomics Genet. 2015 Jan 27;2015(5):53–75. doi: 10.2147/AGG.S74598

Table 7.

snoRNA disturbances for Alström versus lean males

snoRNA Chr Box Host gene Host gene function Fold
change
P-value FDR
Downregulated
 U38B (SNORD38B) 1q34.1 C/D RPS8 Component of 40S ribosomal subunit −1.8 0.01 0.18
 HBII-289 (SNORD89) 2q11.2 C/D RNF149 E3 Ubiquitin-protein ligase,
implicated in pancreatic cancer
−1.6 0.01 0.20
 HBII-95 (SNORD11) 2q33.1 C/D NOP5
NOP58
18S rRNA processing, modulated by sumoylation;
implicated in Kennedy disease and breast cancer
−1.6 0.005 0.12
 U99 (SNORA57) 11q12.3 H/ACA METTL12 18S rRNA processing, putative methyltransferase −1.8 0.001 0.07
 ACA64 (SNORA78) 16p13.3 H/ACA SNHG9 28S rRNA processing, affiliated with long
noncoding RNA
−1.7 0.006 0.13
 ENSG207098
 (SNORA70BL4)
21q22.11 H/ACA AP000281.2 Unknown function, known antisense gene
transcript, processed pseudogene
−3.7 0.001 0.06
 ENSG207002
 (ACA5, SNORA5)
3q21.1 H/ACA MYLK Kinase phosphorylates myosin light chain
to facilitate contraction, disease impact
cardiovascular function
−2.3 0.003 0.10
 ENSG239041
 (snoU13 family)
2q31-q32 RAPGEF4 Associated with COPD, pancreatitis,
regulation of insulin secretion
−2.1 0.009 0.17
 ENSG238934
 (ACA64 family)
1q23.3 DEDD Scaffolding protein involved in apoptosis;
ubinquinated in nucleus; facilitates and directs
caspase-3 activity
−1.8 0.005 0.13
 ENSG252122
 (ACA62, SNORA76 family)
16q23.1 CFDP1 Important for cranial-facial development −1.7 0.006 0.14
 ENSG251992
 (scaRNA17, U91)
18q21.1 C/D 1. ACAA2 or
2. MYO5B
  1. Mitochondrial beta-oxidation in liver, muscle, and fibroblasts

  2. Microvillus inclusion disease-high expression in liver and kidney, recycling of transferrin

−1.6 0.009 0.17
Upregulated
 U13 (SNORD13) 8p12 C/D TTI2 Gene interacts with TELO2, regulates
PIP2 hydrolysis, damage response
2.1 0.01 0.18
 U36B (SNORD36B) 9q34.2 C/D RPL7A
(alt. SURF3)
60S ribosomal protein, thyroid hormone
receptor uncoupling protein
1.6 0.003 0.10
 snR39B (SNORD2) 3q27.3 C/D EIF4A2 Initiation factor for translation with helicase
activity, necessary for small rRNA binding
1.6 0.009 0.17
 U75 (SNORD75) 1q25.1 C/D GAS5
(ncRNA)
28S rRNA processing, growth arrest
related to splicing
1.5 0.002 0.07
 U23 (SNORA75) 2q37.1 H/ACA NCL Acid phosphoprotein in nucleolus, controls
rRNA transcription by pol I, targets 18S rRNA
2.5 0.005 0.12
 ACA45 (scaRNA15) 15q25.2 H/ACA U2 snoRNA FSD2 complementarity 1.8 0.003 0.10
 ENSG252787
 (SNORD19B)
3p21.1 GNL3 Multiple splice variants; depletion or overexpression
of gene inhibits proliferation in CNS
1.8 0.002 0.08
 ENSG238947
 (snoU13 family)
17q25.3 CCDC57-18 Multiple splice variants; unknown gene function;
co-localized with fatty acid synthase which is
elevated in uterine leiomyoma
1.6 0.008 0.16
 ENSG238657
 (snoU13 family)
9q34.2 RALGDS/
CELP
Cellular signaling through Ras 1.6 6.44E-05 0.01
 ENSG252349
 (SNORA31 family)
17p11.2 ALDH3A2 Fatty aldehyde oxidation; associated with
Sjogren-Larsson syndrome
1.5 1.30E-05 0.01

Notes: Data resources: snoRNA Orthological Gene Database (snoopy, http://snoopy.med.miyazaki-u.ac.jp/); Gene Cards (http://www.genecards.org/); OMIM (http://www.omim.org/).

Abbreviations: alt, alternate; Chr, chromosome; CNS, central nervous system; COPD, chronic obstructive pulmonary disease; PIP2, phosphatidylinositol 4,5-bisphosphate; rRNA, ribosomal RNA; SNORA, small nucleolar RNA (H/ACA Box); SNORD, small nucleolar RNA (C/D Box); snoRNA, small nucleolar RNAs; TELO2, telomere maintenance 2.